Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gaitanis, G. Articles by Velegraki, A. Search for Related Content PubMed PubMed Citation Articles by Gaitanis, G. Articles by Velegraki, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2005, p. 4147-4151, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4147-4151.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Novel Application of the Masson-Fontana Stain for Demonstrating Malassezia Species Melanin-Like Pigment Production In Vitro and in Clinical Specimens

George Gaitanis,¹ Vassiliki Chasapi,² and Aristea Velegraki^1*

Mycology Reference Laboratory (Hellenic Centre for Diseases Control), Microbiology Department, Medical School, University of Athens,¹ Third Dermatology Department, National Health System, "A. Sygros" Hospital, Athens, Greece²

Received 8 December 2004/ Returned for modification 4 March 2005/ Accepted 14 April 2005

Top Abstract Text References

 
Melanin-like pigment produced in vitro and in vivo by Malassezia yeasts has not been described before. Masson-Fontana staining confirmed accumulation of black pigment on the cell walls of L-dihydroxyphenylalaline (L-DOPA)-cultured Malassezia species. Black pigment was also observed in cells and hyphae from hyperpigmented patient lesions with culture-confirmed pityriasis versicolor and seborrheic dermatitis.

Top Abstract Text References

 
Melanin production, mediated by a copper-containing phenoloxidase enzyme using L-dihydroxyphenylalaline (L-DOPA) as a substrate, is a well-studied pathogenetic mechanism in fungi (9, 24), especially in species of the human pathogen Cryptococcus. Many properties related to the evasion of the host immune system (9) and antifungal drug resistance (23) have been attributed to melanin or melanin-like pigments, assessed in vitro by growth in L-DOPA agar (18) and in vivo by staining with Masson-Fontana stain, which detects melanin deposited on the cells of this basidiomycetous yeast (10).

The aims of this study were (i) to assess the in vitro abilities of Malassezia yeasts to oxidize L-DOPA and produce a melanin-like pigment and (ii) to demonstrate that this pigment can be detected in yeast cells and hyphae by Masson-Fontana silver staining of skin scales from pityriasis versicolor (PV) and seborrheic dermatitis (SD) patients.

We studied 53 type, reference, and clinical isolates of 11 Malassezia species (Table 1) (7, 8, 20-22). The type and reference strains for this study were obtained from the Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands. The clinical isolates were strains kept in the Mycology Reference Laboratory of the Hellenic National Collection of Pathogenic Fungi (HNCPF; World Data Centre on Microorganisms member type ID 2023). All Malassezia strains, the control Cryptococcus grubii strains (HNCPF 6417a and 6417b) demonstrating maximum and no melanization, respectively, and the autochthonous clinical Cryptococcus gattii serotype B (HNCPF 55/CBS10090, HNCPF 54W/CBS10088) strains with various degrees of melanization, as well as nonmelanized Cryptococcus laurentii (HNCPF 02/NCPF 3832 [National Collection for Pathogenic Fungi, Bristol, United Kingdom]) were semiquantitatively tested for their abilities to produce pigment when grown in lipid-supplemented and lipid-depleted L-DOPA and tyrosine agars. Briefly, 1 liter of medium comprised 200 ml filter-sterilized (0.2 µm; catalog no. 14831; Corning, Germany) water solution at pH 5.5 (adjusted with 1 M potassium dihydrogen phosphate [KH₂PO₄]) supplemented with 0.04 g L-DOPA or tyrosine, 1 g asparagine, 1 g L-glutamine, and 1 g glycine (all from Sigma, Saint Louis, Mo.). This solution was mixed with 800 ml of a sterile solution, cooled to approximately 50°C, of 4 g KH₂PO₄, 2.5 g hydrated magnesium sulfate (MgSO₄ · 7H₂O), 10 mg thiamine HCl, 20 µg biotin, 0.5 g glucose, 25 g agar, 4 g OxBile, 1 ml glycerol, 0.5 g glycerol monostearate, and 0.4 ml Tween 20, readjusted at pH 5.5 with KH₂PO₄ (all from Sigma).

View this table: [in this window] [in a new window]

TABLE 1. Intensity of melanization displayed by 11 Malassezia species in L-DOPA agar

Phenoloxidase activity in the Cryptococcus control and the Malassezia strains was corroborated by modifying the semiquantitative method of Cooper and Christine-Brown (2). Briefly, half the agar plate contained L-DOPA medium (0.005% L-DOPA [wt/vol], 2% Bacto Agar in 0.1 M phosphate buffer solution [all from Sigma]) and the other half contained a control medium without the addition of L-DOPA. The solidified agar surface was punctured with a standard sterile 5-mm-diameter cork borer, producing wells. In each well, 100 µl of whole-cell suspensions or cells that had been aseptically mechanically disrupted by an orbital homogenizer at 100 rpm and suspended in sterile water was inoculated and incubated at 35°C for 3 and 7 days for the Cryptococcus and Malassezia strains, respectively (Fig. 1A and 2B). All plates were inspected daily for pigment production. Absence of a lipid source in the culture medium did not allow growth of Malassezia yeasts.

View larger version (47K): [in this window] [in a new window]

FIG. 1. (A) Various degrees of melanization in L-DOPA agar displayed by reference control cultures of Cryptococcus gattii and Cryptococcus laurentii. (B) Melanization of Cryptococcus neoformans in Bacto (control) and L-DOPA (test) agars in wells 1 to 4. Wells: 1, C. grubii (HNCPF 6417a); 2, C. neoformans serotype D (HNCPF 17); 3, C. neoformans serotype AD (HNCPF 34); 4, C. grubii (HNCPF 6417b).

View larger version (79K): [in this window] [in a new window]

FIG. 2. (A) Intense melanization of M. dermatis CBS9169, grown in L-DOPA medium at 35°C for 7 days. (B) Demonstration of melanization by M. sympodialis CBS8741 tested by the modified method of Cooper and Christine-Brown after incubation at 35°C for 12 days. Wells: 1, whole cells; 2, mechanically disrupted cells inoculated into the wells. Arrow indicates precipitation of melanin-like pigment. (C) Intensely melanized Masson-Fontana silver-stained Malassezia cells from hyperpigmented PV lesions (original magnification, x1,000). (D) Pink (nonmelanized) appearance of Malassezia cells from hypopigmented PV lesions (original magnification, x1,000).

The Masson-Fontana silver stain was employed to demonstrate melanin deposition (10) on the walls of Malassezia cells harvested from tyrosine and L-DOPA media, respectively. In order to ascertain the necessity for L-DOPA in the synthesis of melanin, cells grown in the L-DOPA-depleted medium were also tested for melanin-like pigment detection by Masson-Fontana staining. To examine whether melanin-like pigment can be directly detected in Malassezia yeasts parasitizing the skin of patients, multiple skin scale specimens from 15 Caucasian patients with hyperpigmented PV lesions, 15 patients with hypopigmented PV lesions, and 7 SD patients were tested for deposition of dark-brown to black pigment in vivo by Masson-Fontana staining. At least six different lesions from each patient were sampled. The presence of Malassezia yeasts was culture confirmed, and the yeasts were identified to species level (6, 7). Informed consent was obtained at all times. Specimens from six hypopigmented and six hyperpigmented lesions were obtained from one Caucasian female patient who presented with both types of macula.

No oxidation of tyrosine was detected when Malassezia yeasts were grown on tyrosine agar, indicating that melanogenesis may occur via a tyrosinase-independent pathway. By contrast, Malassezia strains tested on L-DOPA agar produced a pigment with various melanization intensities. Malassezia dermatis strains demonstrated maximum, and M. furfur demonstrated minimum, pigment production (Table 1; Fig. 2A). In the Cryptococcus melanin production model, C. gattii CBS10090 demonstrated the maximum melanization and C. grubii HNCPF 6417b demonstrated the minimum (Fig. 1B). The L-DOPA substrate was oxidized only after Malassezia membrane disruption (Fig. 2A), suggesting that phenoloxidase, the enzyme mediating melanin production, may not be secreted, but either attached to the cell wall or bound to the membrane as in Cryptococcus neoformans (14). Variable oxidation of the medium was also noted with the disrupted cryptococcal cells (Fig. 1).

Masson-Fontana staining showed a melanin-like pigment deposited in the walls of L-DOPA-grown mature yeast cells, while differential melanization intensity was observed in mother and daughter cells (data not shown). The intensity of fungal wall pigmentation was proportional to the intensity of melanization displayed in the L-DOPA medium (Table 1). Therefore, the M. furfur strains that produced minimum or no pigment in L-DOPA agar counterstained pink, indicating lack of melanin-like pigment. Similarly, the C. grubii and C. gattii strains demonstrated various degrees of melanization in L-DOPA agar and upon Masson-Fontana staining, whereas no pigment was detected in the nonmelanized C. laurentii and C. grubii strains.

The results confirmed that melanization takes place in vivo, as evidenced by the fact that skin scales originating from hyperpigmented PV and SD lesions, even those from the patient displaying both types of lesions, showed Masson-Fontana-positive (dark-brown to black) Malassezia cells and hyphae (Fig. 2C). Furthermore, the positive Masson-Fontana staining of Malassezia yeasts from hyperpigmented lesions of the epidermal keratin layer demonstrated melanin-like pigment accumulation (Fig. 2C). All isolates from hyperpigmented PV lesions were M. sympodialis, and all those from SD lesions were M. restricta (Table 1). M. sympodialis was isolated from the hyperpigmented and M. furfur from the hypopigmented lesions of the same patient. No melanin-like pigment was detected in yeast cells and hyphae in skin scales from the hypopigmented PV lesions (Fig. 2D). The statistical importance of this finding was not assessed, because the clinical implications of melanin production were not examined in this study.

The Gomori-Grocott silver stain has been used twice in the past to demonstrate the implication of Malassezia yeasts in systemic infections (16, 19) and was found superior (19) to periodic acid-Schiff in demonstrating fungal elements in tissue, but no explanation was provided for that finding. In earlier studies, hypertrophy of melanocytes had been noted in postinflammatory hyperpigmentation (12), whereas almost a decade later, controversy existed as to whether the distribution pattern and size of melanosomes were associated with hyperpigmentation (1, 3). However, the various degrees of Malassezia species and strain melanization observed in culture and in hyperpigmented-lesion material (Table 1; Fig. 2C) correlate with previous findings on hyperpigmented, nonvitiliginous tinea versicolor skin sections examined by periodic acid-Schiff staining, Fontana staining, and electron microscopy (1, 3). Furthermore, the isolation of pityriacitrin (11), a UV-absorbing indole alkaloid, from M. furfur sensu stricto correlates with the recorded reduced capacity of M. furfur sensu stricto for melanization in vivo and in vitro (Table 1; Fig. 2D) and with previous observations that epidermal melanin is absent from vitiliginous skin specimens affected by tinea versicolor (3), although the latter was attributed to M. furfur sensu lato. Coevaluation of these observations might contribute to elucidating the causative mechanism involved in hypopigmentation and variable fluorescence phenomena documented in PV.

Melanization, as visualized by the positive Masson-Fontana staining of Malassezia yeast cells and hyphae in vivo, indicates the presence of L-DOPA in the epidermal cells. However, the occurrence of L-DOPA in the epidermis is thus far supported by indirect evidence, based on the detection of a specialized L-DOPA transport system in the Langerhans cells, while L-DOPA uptake takes place in the epidermis (5). Whether this phenomenon takes place in deeper layers of the epidermis and within the sebaceous gland or whether pigmentary changes in PV also require the involvement of factors besides those involved in normal skin pigmentation, such as melanosomes (1), has not been fully clarified.

Melanins are important biologically active compounds with recognized virulence properties (9). For Cryptoccoccus, a basidiomycetous yeast phylogenetically close to Malassezia, intensive research during the past 30 years was required to elucidate the significance of melanization in virulence, immunomodulation, and neurotropism. Also, the demonstration of diphenoloxidase activity in the neurotropic Mycobacterium leprae further supported the importance of this pathway in human pathogens that can use melanin as an immunomodulator (15, 17).

The proposed Masson-Fontana staining for evaluation of the production of melanin-like pigment by Malassezia species has potential applications in clinical and laboratory studies. Melanin in Cryptococcus has been shown to have the ability to activate the complement pathway (17). A key element in the pathogenesis of SD (4) is the activation of the complement pathway. Thus, studies of complement activation by melanin-producing Malassezia strains, coupled with assessment of melanin production in SD lesions by Masson-Fontana staining of skin scales and biopsy material, could highlight aspects of SD pathogenesis. Intensely melanized Cryptococcus strains demonstrate reduced amphotericin B susceptibility (23). Whether the relapses of SD episodes after maintenance topical therapy with amphotericin B (13) are correlated with melanized Malassezia yeasts is an issue for clinical investigation. Clinical observations concerning reinstatement of normal skin pigment following successful treatment, (13) suggest that the melanin-like pigment production reported here is elicited by Malassezia yeasts.

In conclusion, the presence of melanin-like pigment in Malassezia yeasts, as confirmed following growth on modified L-DOPA agar and demonstrated in lesion material (skin scales) by Masson-Fontana staining, offers a novel, simple, and cost-effective method for the assessment of this important biological function in the pathogenesis of Malassezia-induced dermatoses.

 
Materials were provided by the Athens University Medical School, grant 4121-10/2004.

We express our appreciation to E. Agapitos, Pathology and Anatomy Department, Medical School, University of Athens, for expert advice on histological staining. We also express our gratitude to S. Kritikou for proficient and conscientious technical assistance.

 
* Corresponding author. Mailing address: Mycology Reference Laboratory, Department of Microbiology, Medical School, University of Athens, Mikras Asias 75-77, Goudi, Athens 115 27, Greece. Phone: 30210 746 2146. Fax: 30210 746 2147. E-mail: aveleg{at}med.uoa.gr.

Top Abstract Text References

 

1
1. Allen, H. B., C. R. Charles, and B. L. Johnson. 1976. Hyperpigmented tinea versicolor. Arch. Dermatol. 21:1110-1112.
2
2. Cooper, J. A., and F. Christine-Brown. 1956. A rapid semi-quantitative method for the assay of tyrosinase activity. Clin. Chim. Acta 1:301-304.[CrossRef][Medline]
3
3. Dotz, W. I., D. M. Henrikson, G. S. M. Yu, and C. I. Galley. 1985. Tinea versicolor: a light and electron microscopic study of hyperpigmented skin. J. Am. Acad. Dermatol. 12:37-44.[Medline]
4
4. Faergemann, J., I.-M. Bergbrant, M. Dohsé, A. Scott, and G. Westgate. 2001. Seborrheic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br. J. Dermatol. 144:549-556.[CrossRef][Medline]
5
5. Falck, B., N. Bendsoe, and G. Ronquist. 2003. New mechanism for amino acid influx into human epidermal Langerhans cells: L-DOPA/proton counter-transport system. Exp. Dermatol. 12:602-609.[CrossRef][Medline]
6
6. Gaitanis, G., A. Velegraki, E. Frangoulis, A. Mitroussia, A. Tsimogianni, A. Tsigonia, A. Katsambas, and N. J. Legakis. 2002. Identification of Malassezia species from patient skin scales by PCR-RFLP. Clin. Microbiol. Infect. 8:162-173.[CrossRef][Medline]
7
7. Guého, E., G. Midgley, and J. Guillot. 1996. The genus Malassezia with description of four new species. Antonie Leeuwenhoek 69:337-355.
8
8. Hirai, A., R. Kano, K. Makimura, E. R. Duarte, J. S. Hamdan, M. A. Lachance, H. Yamaguchi, and A. Hasegawa. 2004. Malassezia nana sp. nov., a novel lipid-dependent yeast species isolated from animals. Int. J. Syst. Evol. Microbiol. 54:623-627.[Abstract/Free Full Text]
9
9. Jacobson, E. 2000. Pathogenic roles for fungal melanins. Clin. Microbiol. Rev. 13:708-717.[Abstract/Free Full Text]
10
10. Kwon-Chung, K. J., W. B. Hill, and J. E. Bennett. 1981. New, special strain for the histopathological diagnosis of cryptococcosis. J. Clin. Microbiol. 13:383-387.[Abstract/Free Full Text]
11
11. Mayser, P., U. Schäfer, H.-J. Krämer, B. Irlinger, and W. Steglich. 2002. Pityriacitrin—an ultraviolet-absorbing indole alkaloid from the yeast Malassezia furfur. Arch. Dermatol. Res. 294:131-134.[CrossRef][Medline]
12
12. Papa, C. M., and A. M. Kligman. 1965. The behavior of melanocytes in inflammation. J. Investig. Dermatol. 45:465-473.[Medline]
13
13. Plewig, G., and T. Jansen. 1999. Seborrheic dermatitis, p. 1482-1489. In I. M. Freedberg, A. Z. Eisen, K. Wolff, K. F. Austen, L. A. Goldsmith, S. I. Katz, and T. B. Fitzpatrick (ed.), Fitzpatrick's dermatology in general medicine. McGraw-Hill, New York, N.Y.
14
14. Polacheck, I., V. J. Hearing, and K. J. Kwon-Chung. 1982. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J. Bacteriol. 150:1212-1220.[Abstract/Free Full Text]
15
15. Prabhakaran, K. 1971. Unusual effects of reducing agents on o-diphenoloxidase of Mycobacterium leprae. J. Bacteriol. 107:787-789.[Abstract/Free Full Text]
16
16. Redline, R., and B. Barrett-Dahms. 1981. Malassezia pulmonary vasculitis in an infant on long-term intralipid therapy. N. Engl. J. Med. 35:1395-1398.
17
17. Rosas, A. L., R. S. MacGill, J. D. Nosanchuk, T. R. Kozel, and A. Casadevall. 2002. Activation of the alternative complement pathway by fungal melanins. Clin. Diagn. Lab. Immunol. 9:144-148.[Abstract/Free Full Text]
18
18. Shaw, C. E., and L. Kapica. 1972. Production of diagnostic pigment by phenoloxidase activity of Cryptococcus neoformans. Appl. Microbiol. 24:824-830.[Medline]
19
19. Shek, Y. H., M. Tucker, A. Viciana, H. Manz, and D. Conor. 1989. Malassezia furfur—disseminated infection in premature infant. Am. J. Clin. Pathol. 92:595-603.[Medline]
20
20. Sugita, T., M. Tajima, M. Takashima, M. Amaya, M. Saito, R. Tsuboi, and A. Nishikawa. 2004. A new yeast, Malassezia yamatoensis, isolated from a patient with seborrheic dermatitis, and its distribution in patients and healthy subjects. Microbiol. Immunol. 48:579-583.[Medline]
21
21. Sugita, T., M. Takashima, M. Kodama, R. Tsuboi, and A. Nishikawa. 2003. Description of a new yeast species, Malassezia japonica, and its detection in patients with atopic dermatitis and healthy subjects. J. Clin. Microbiol. 41:4695-4699.[Abstract/Free Full Text]
22
22. Sugita, T., M. Takashima, T. Shinoda, H. Suto, T. Unno, R. Tsuboi, H. Ogawa, and A. Nishikawa. 2002. New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J. Clin. Microbiol. 40:1363-1367.[Abstract/Free Full Text]
23
23. Van Duin, D., A. Casadevall, and J. D. Nosanchuk. 2002. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob. Agents Chemother. 46:3394-3400.[Abstract/Free Full Text]
24
24. Wood, C., and B. Russel-Bell. 1983. Characterization of pigmented fungi by melanin staining. Am. J. Dermatopathol. 5:77-81.[Medline]

---

Journal of Clinical Microbiology, August 2005, p. 4147-4151, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4147-4151.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gaitanis, G. Articles by Velegraki, A. Search for Related Content PubMed PubMed Citation Articles by Gaitanis, G. Articles by Velegraki, A.